AVTR Insider Trading
Avantor, Inc. | Laboratory Analytical Instruments
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Avantor, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Laboratory Analytical Instruments sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2021-08-14 00:10 | 2021-07-12 | Natauri Jo | Director | BUY | $36.33 | 300 | $10,900 | 557,656 | +0.1% |
| 2021-08-02 23:42 | 2021-07-30 | Brophy Gerard | Officer - EVP, Biopharma Production | OPT+S | $37.24 | 81,125 | $3,021,095 | 149,379 | 0.0% |
| 2021-07-22 00:04 | 2021-07-20 | Bramwell James | Officer - EVP, Strategic Partners | SELL | $37.00 | 6,112 | $226,144 | 79,899 | -7.1% |
| 2021-07-14 00:32 | 2021-07-09 | Bramwell James | Officer - EVP, Strategic Partners | SELL | $35.61 | 18,331 | $652,827 | 86,011 | -17.6% |
| 2021-06-30 00:11 | 2021-06-28 | Couturier Christophe | Officer - EVP, AMEA | SELL | $35.73 | 28,096 | $1,003,870 | 110,077 | -20.3% |
| 2021-06-28 23:55 | 2021-06-25 | GUPTA RAJIV | Director | SELL | $35.32 | 68,605 | $2,423,129 | 1,379,347 | -4.7% |
| 2021-06-11 01:55 | 2021-06-08 | Stubblefield Michael | Director, Officer - President and CEO | OPT+S | $32.13 | 487,700 | $15,667,509 | 1,403,281 | 0.0% |
| 2021-05-28 23:48 | 2021-05-27 | Ohri Devashish | Officer - EVP, IMEA | OPT+S | $31.99 | 100,000 | $3,199,000 | 139,095 | 0.0% |
| 2021-05-28 23:48 | 2021-05-26 | GUPTA RAJIV | Director | SELL | $31.91 | 228,109 | $7,278,297 | 278,109 | -45.1% |
| 2021-05-27 23:53 | 2021-05-26 | Ohri Devashish | Officer - EVP, IMEA | OPT+S | $31.87 | 15,000 | $478,050 | 139,095 | 0.0% |
| 2021-05-27 00:43 | 2021-05-24 | GUPTA RAJIV | Director | SELL | $31.66 | 337,571 | $10,687,700 | 506,218 | -40.0% |
| 2021-05-26 00:08 | 2021-05-24 | Ohri Devashish | Officer - EVP, IMEA | OPT+S | $31.75 | 9,124 | $289,687 | 139,095 | 0.0% |
| 2021-05-25 00:14 | 2021-05-21 | Wondrasch Michael | Officer - EVP & CIO | SELL | $31.41 | 18,488 | $580,708 | 113,295 | -14.0% |
| 2021-05-21 23:55 | 2021-05-20 | Miller Justin | Officer - EVP & General Counsel | SELL | $31.12 | 18,488 | $575,347 | 86,536 | -17.6% |
| 2021-05-21 23:54 | 2021-05-20 | Brophy Gerard | Officer - EVP, Biopharma Production | SELL | $31.10 | 19,603 | $609,653 | 149,379 | -11.6% |
| 2021-05-21 23:55 | 2021-05-20 | Couturier Christophe | Officer - EVP, AMEA | SELL | $31.13 | 25,010 | $778,561 | 138,173 | -15.3% |
| 2021-05-14 00:47 | 2021-05-11 | Natauri Jo | Director | SELL | $30.68 | 2,626,771 | $80,589,334 | 24,807,518 | -9.6% |
| 2021-05-07 23:06 | 2019-05-17 | Natauri Jo | Director | SELL | $16.33 | 321,777 | $5,253,653 | 72,620,082 | -0.4% |
| 2021-05-07 23:06 | 2019-05-17 | Natauri Jo | Director | BUY | $16.33 | 320,827 | $5,240,356 | 72,630,004 | +0.4% |
| 2021-05-07 23:05 | 2019-05-17 | Connolly Thomas | Director | SELL | $16.33 | 321,777 | $5,253,653 | 72,620,082 | -0.4% |
| 2021-05-07 23:05 | 2019-05-17 | Connolly Thomas | Director | BUY | $16.33 | 320,827 | $5,240,356 | 72,630,004 | +0.4% |
| 2021-05-07 23:05 | 2019-05-17 | GOLDMAN SACHS & CO. LLC | 10% owner | SELL | $16.33 | 321,777 | $5,253,653 | 72,620,082 | -0.4% |
| 2021-05-07 23:05 | 2019-05-17 | GOLDMAN SACHS & CO. LLC | 10% owner | BUY | $16.33 | 320,827 | $5,240,356 | 72,630,004 | +0.4% |
| 2021-05-05 00:06 | 2021-04-30 | Ohri Devashish | Officer - EVP, IMEA | OPT+S | $32.58 | 53,649 | $1,747,884 | 155,888 | 0.0% |
| 2021-04-14 01:03 | 2021-04-12 | Ohri Devashish | Officer - EVP, IMEA | OPT+S | $32.37 | 100,160 | $3,242,179 | 155,888 | 0.0% |
| 2021-04-14 01:03 | 2021-04-12 | Vanderhaegen Frederic | Officer - EVP, Europe | SELL | $31.80 | 27,075 | $860,999 | 216,594 | -11.1% |
| 2021-04-14 01:02 | 2021-04-12 | Bramwell James | Officer - EVP, Strategic Partners | SELL | $32.00 | 2,505 | $80,160 | 118,136 | -2.1% |
| 2021-04-14 01:02 | 2021-04-12 | Miller Justin | Officer - EVP & General Counsel | OPT+S | $33.17 | 102,895 | $3,412,914 | 118,679 | 0.0% |
| 2021-03-11 01:08 | 2021-03-09 | Vanderhaegen Frederic | Officer - EVP, Europe | SELL | $28.21 | 10,000 | $282,100 | 243,669 | -3.9% |
| 2021-03-04 01:11 | 2021-03-02 | Wondrasch Michael | Officer - EVP & CIO | SELL | $28.71 | 3,036 | $87,164 | 145,438 | -2.0% |
| 2021-02-27 02:34 | 2021-02-24 | Brophy Gerard | Officer - EVP, Biopharma Production | SELL | $27.93 | 3,059 | $85,438 | 172,384 | -1.7% |
| 2021-02-24 01:51 | 2021-02-22 | Brophy Gerard | Officer - EVP, Biopharma Production | OPT+S | $28.62 | 19,769 | $565,789 | 175,443 | 0.0% |
| 2021-02-09 02:23 | 2021-02-05 | Wondrasch Michael | Officer - EVP & CIO | OPT+S | $29.77 | 49,468 | $1,472,662 | 141,543 | 0.0% |
| 2021-01-14 01:43 | 2021-01-11 | Bramwell James | Officer - EVP, Strategic Partners | SELL | $30.00 | 2,505 | $75,150 | 116,430 | -2.1% |
| 2021-01-14 01:41 | 2021-01-11 | Brophy Gerard | Officer - EVP, Biopharma Production | OPT+S | $30.06 | 378,580 | $11,381,213 | 178,515 | 0.0% |
| 2021-01-09 03:31 | 2021-01-06 | Brophy Gerard | Officer - EVP, Biopharma Production | SELL | $27.24 | 11,509 | $313,505 | 178,515 | -6.1% |
| 2021-01-07 05:06 | 2021-01-04 | Brophy Gerard | Officer - EVP, Biopharma Production | OPT+S | $27.84 | 59,418 | $1,654,197 | 190,024 | 0.0% |
| 2020-12-24 01:10 | 2020-12-21 | Bramwell James | Officer - EVP, Strategic Partners | SELL | $27.14 | 10,020 | $271,943 | 117,768 | -7.8% |
| 2020-12-16 03:16 | 2020-12-11 | Shaw Christi | Director | SELL | $26.68 | 14,286 | $381,150 | 11,319 | -55.8% |
| 2020-12-09 03:09 | 2020-12-04 | Stubblefield Michael | Director, Officer - President and CEO | OPT+S | $27.15 | 510,640 | $13,864,540 | 1,847,265 | 0.0% |
| 2020-11-13 03:35 | 2020-06-11 | Natauri Jo | Director | SELL | $17.13 | 39,118 | $670,064 | 58,861,086 | -0.1% |
| 2020-11-13 03:35 | 2020-06-11 | Natauri Jo | Director | BUY | $17.25 | 15,199 | $262,244 | 58,861,148 | +0.0% |
| 2020-11-13 03:31 | 2020-06-11 | GOLDMAN SACHS & CO. LLC | 10% owner | SELL | $17.13 | 39,118 | $670,064 | 58,861,086 | -0.1% |
| 2020-11-13 03:31 | 2020-06-11 | GOLDMAN SACHS & CO. LLC | 10% owner | BUY | $17.25 | 15,199 | $262,244 | 58,861,148 | +0.0% |
| 2020-11-11 05:24 | 2020-11-10 | New Mountain Investments III, LLC | 10% owner | SELL | $24.81 | 36,016,093 | $893,490,837 | 28,000,000 | -56.3% |
| 2020-10-08 03:23 | 2020-10-05 | Ohri Devashish | Officer - EVP, IMEA | OPT+S | $23.42 | 103,440 | $2,422,348 | 151,671 | 0.0% |
| 2020-09-17 23:39 | 2020-09-16 | Ohri Devashish | Officer - EVP, IMEA | OPT+S | $23.02 | 35,000 | $805,700 | 151,671 | 0.0% |
| 2020-09-09 23:43 | 2020-09-08 | Miller Justin | Officer - EVP & General Counsel | SELL | $21.17 | 22,887 | $484,518 | 113,507 | -16.8% |
| 2020-08-26 03:46 | - | Natauri Jo | Director | SELL | $19.51 | 15,397,005 | $300,341,678 | 43,483,708 | -26.1% |
| 2020-08-26 03:40 | - | GOLDMAN SACHS & CO. LLC | 10% owner | SELL | $19.51 | 15,397,005 | $300,341,678 | 43,483,708 | -26.1% |
How to Interpret $AVTR Trades
Not every insider transaction in Avantor, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $AVTR shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for AVTR
Insider activity data for Avantor, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $AVTR, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.